The arrangement, the first of its kind in the UK, gave DeepMind (a company owned by Alphabet, the parent company of Google) access to 1.6 million Royal Free patient’s medical data in order for DeepMind to carry out clinical safety testing on their new software ‘Streams’. Streams is being developed to improve the care of patients with Acute Kidney Injury through an algorithm which alerted staff of new lab results which could speed up patient care.